|
SETDB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.816800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.416350E-03 |
| Normal-vs-Stage2 |
8.321800E-03 |
| Normal-vs-Stage3 |
6.034300E-04 |
| Normal-vs-Stage4 |
1.948490E-02 |
| Stage1-vs-Stage2 |
7.075000E-01 |
| Stage1-vs-Stage3 |
3.444800E-01 |
| Stage1-vs-Stage4 |
9.844200E-01 |
| Stage2-vs-Stage3 |
7.741000E-01 |
| Stage2-vs-Stage4 |
7.685000E-01 |
| Stage3-vs-Stage4 |
5.215800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.464820E-03 |
| Normal-vs-AfricanAmerican |
2.327600E-01 |
| Normal-vs-Asian |
2.993800E-02 |
| Caucasian-vs-AfricanAmerican |
3.157000E-01 |
| Caucasian-vs-Asian |
5.149000E-01 |
| AfricanAmerican-vs-Asian |
5.243800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.880500E-03 |
| Normal-vs-Female |
3.639000E-04 |
| Male-vs-Female |
6.131000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.540540E-03 |
| Normal-vs-Age(41-60Yrs) |
1.236820E-03 |
| Normal-vs-Age(61-80Yrs) |
7.460400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.039500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.228400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.581800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.156800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.340000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.197800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.604000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.444100E-03 |
| Classical-VS-Follicular |
2.232100E-04 |
| Classical-VS-Other |
3.101200E-01 |
| Classical-VS-Normal |
2.052000E-02 |
| Tall-VS-Follicular |
6.975200E-01 |
| Tall-VS-Other |
6.371400E-01 |
| Tall-VS-Normal |
1.558510E-04 |
| Follicular-VS-Other |
8.288800E-01 |
| Follicular-VS-Normal |
4.19940000000452E-05 |
| Other-VS-Normal |
8.706300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.635900E-04 |
| Normal-vs-N1 |
8.403200E-03 |
| N0-vs-N1 |
8.559800E-01 |
|
|
